ClinicalTrials.Veeva

Menu

Evaluate Dental Plaque Benefit of a Preventive Treatment Gel

Procter & Gamble (P&G) logo

Procter & Gamble (P&G)

Status and phase

Completed
Phase 3

Conditions

Dental Plaque

Treatments

Drug: Marketed Control
Drug: Preventive Gel

Study type

Interventional

Funder types

Industry

Identifiers

NCT03546491
2018009

Details and patient eligibility

About

The objective of the study is to evaluate anti-plaque efficacy of a preventive treatment gel in a modified 4-day plaque model.

Enrollment

32 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Provide written informed consent prior to participation and be given a signed copy of the informed consent form;
  • Be 18 years of age or older;
  • Agree not to participate in any other oral/dental product studies during the study;
  • Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed;
  • Agree to refrain from the use of any non-study oral hygiene products (subjects who are regular flossers will be allowed to floss during acclimation and wash-out periods);
  • Agree to use an oral hygiene product that contains stannous fluoride;
  • Agree to refrain from any form of non-specified oral hygiene during the treatment period, including the use of products such as floss, toothpicks for plaque removal, and chewing gum;
  • Agree to refrain from any oral hygiene, eating and drinking after 11:00 PM the evening before plaque measurements on Day 0 and Day 4 of the treatment periods;
  • Agree to return for all scheduled visits and follow study procedures;
  • Possess a minimum of 20 natural teeth with scorable facial and lingual surfaces, of which at least 4 are molars; and,
  • Be in good general health, as determined by the Investigator/designee based on a review of the health history/update for participation in the study.

Exclusion Criteria:• Have a medical condition requiring pre-medication prior to dental procedures;

  • Have taken antibiotics within 2 weeks of the acclimation period or anticipate taking antibiotics at any time during the study;
  • Have a history of allergies or hypersensitivity to dyes or dentifrices that contain stannous fluoride;
  • Have removable or orthodontic appliances which interfere with obtaining 20 gradable teeth;
  • Have previously demonstrated an inability to comply with study visit requirements;
  • Have rampant caries, open or untreated caries, severe gingivitis or advanced periodontitis requiring prompt treatment; or,
  • Present with any disease or condition(s) that could be expected to interfere with examination procedures or the subject's safe completion of the study.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

32 participants in 2 patient groups

Preventive Gel
Experimental group
Description:
0.4% stannous fluoride
Treatment:
Drug: Preventive Gel
Marketed Control
Active Comparator group
Description:
0.243 % Sodium Fluoride
Treatment:
Drug: Marketed Control

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems